Share：
Share this content in WeChat
X
[Chinese][PDF]940100
• Review •
Advances in imaging of tumefactive demyelinating lesions
LI Ying  LI Yong-mei 

DOI:10.3969/j.issn.1674-8034.2015.03.014.


[Abstract] Tumefactive demyelinating lesions (TDLs) is a rare and intriguing form of central nervous system demyelinating disorder. It is often misdiagnosed as intracranial gliomas, lymphoma, etc. Thus correct diagnosis can avoid unnecessary surgery and radiotherapy damage. This article aims to review the imaging advances of TDLs and to propose an approach to differential diagnosis of this disease.
[Keywords] Demyelinating diseases；Magnetic resonance imaging；Diagnosis, differential

LI Ying Department of Radiology, the First Affliated Hospital, Chongqing Medical University, Chongqing 400016, China

LI Yong-mei* Department of Radiology, the First Affliated Hospital, Chongqing Medical University, Chongqing 400016, China

*Correspondence to: Li YM, E-mail: lymzhang70@aliyun.com

Conflicts of interest   None.

Received  2014-09-09
Accepted  2014-11-22
DOI: 10.3969/j.issn.1674-8034.2015.03.014
DOI:10.3969/j.issn.1674-8034.2015.03.014.

[1]
Rovira A. Tumefactive idiopathic inflammatory demyelinating lesions: a diagnostic challenge. Mult Scler, 2014, 20(5): 634-635.
[2]
Kiriyama T, Kataoka H, Kasai T, et al. Negative association of Epstein-Barr virus orherpes simplex virus-1 with tumefactive central nervous system inflammatory demyelinating disease. J Neurovirol, 2010, 16(6): 466-471.
[3]
Hardy TA, Chataway J. Tumefactive demyelination: an approach to diagnosis and management. J Neurol Neurosurg Psychiatry, 2013, 84(9): 1047-1053.
[4]
苗延巍，魏强，韩睿，等．多发性硬化斑块周围正常表现白质的磁敏感加权成像及动态磁敏感增强灌注成像．磁共振成像, 2011, 2(4): 273-277.
[5]
周福庆，龚洪翰. 1例复发缓解型多发性硬化MRI连贯分析．磁共振成像, 2011, 2(4): 314-316.
[6]
Hane A, Bargetzi M, Hewer E, et al. Recurrent tumefactive demyelination without evidence of multiple sclerosis or brain tumour. J Neurol, 2011, 258(2): 318-320.
[7]
付峰，陈振东，董海波，等．脑内脱髓鞘假瘤MRI及病理学特征．中国临床医学影像杂志, 2011, 22(12): 871-873.
[8]
Yang Y, Wu WP, Huang DH, et al. Value of anti-aquaporin-4 antibody on Chinese patients with neuromyelitis optica. Chin J Magn Reson Imaging, 2011, 2(4): 267-272.
[9]
Kobayashi M, Shimizu Y, Shibata N, et al. Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology. J Neurol, 2014, 261(10): 1902-1910.
[10]
王保茎，秦全波，毛怡盛，等．脑内脱髓鞘假瘤病理、临床与磁共振成像对照分析．中国医药科学, 2013, 3(17): 143-144.
[11]
Saini J, Chatterjee S, Thomas B, et al. Conventional and advanced magnetic resonance imaging in tumefactive demyelination. Acta Radiol, 2011, 52(10): 1159-1168.
[12]
程刚，黄楹．颅内瘤样脱髓鞘病变的诊治分析．第三军医大学学报, 2014, 36(2): 144-147.
[13]
Adamek D, Radwanska E, Rog T, et al. Tumefactive demyelinating lesion. Trying to find unity in diversity: comparison of two cases. Clin Neurol Neurosurg, 2014,116(1): 90-92.
[14]
Altintas A, Petek B, Isik N, et al. Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study. Mult Scler, 2012, 18(10): 1448-1453.
[15]
Wattamwar PR, Baheti NN, Kesavadas C, et al. Evolution and long term outcome in patients presenting with large demyelinating lesions as their first clinical event. J Neurol Sci, 2010, 297(1-2): 29-35.
[16]
Javalkar V, Manix M, Wilson J, et al. Open ring enhancement in atypical brain demyelination. J Clin Neurosci, 2012, 19(6): 910-912.
[17]
Medeiros FC, Albuquerque LA, Pittella JE, et al. Open-ring enhancement in pseudotumoral multiple sclerosis: important radiological aspect. Case Rep Neurol Med, 2014, 2014(1): 1-5.
[18]
冯逢．多发性硬化的常见MRI征象分析．磁共振成像, 2011, 2(4): 309-313.
[19]
Kiriyama T, Kataoka H, Taoka T, et al. Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm. J Neuroimaging, 2011, 21(2): 69-77.
[20]
Roemer SF, Scheithauer BW, Varnavas GG, et al. Tumefactive demyelination and glioblastoma: a rare collision lesion. Clin Neuropathol, 2011, 30(4): 186-191.
[21]
Kilic AK, Kurne AT, Oguz KK, et al. Mass Lesions in the Brain: Tumor or Multiple Sclerosis? Clinical and imaging characteristics and course from a single reference center. Turk Neurosurg, 2013, 23(6): 728-735.
[22]
Saini J, Chatterjee S, Thomas B, et al. Conventional and advanced magnetic resonance imaging in tumefactive demyelination. Acta Radiol, 2011, 52(10): 1159-1168.
[23]
Malhotra HS, Jain KK, Agarwal A, et al. Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy. Mult Scler, 2009, 15(2): 193-203.
[24]
Majós C, Aguilera C, Alonso J, et al. Proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses. AJNR Am J Neuroradiol, 2009, 30: 544-551.
[25]
余峰，刘晓敏，胡向阳，等．经病理证实颅内肿瘤样脱髓鞘病变患者临床及影像学分析．立体定向和功能性神经外科杂志, 2013, 26(2): 80-84.
[26]
Lu SS, Kim SJ, Kim HS, et al. Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions. AJNR Am J Neuroradial, 2014, 35(2): 270-277.
[27]
罗海营，黄飚，刘红军，等．短TE 1H MRS, Glx峰鉴别脑内脱髓鞘假瘤和星形细胞瘤的价值．临床放射学杂志, 2011, 30(4): 456-459.
[28]
李咏梅，谢鹏，吕发金，等．动态磁敏感增强灌注成像对假瘤样脱髓鞘病的诊断价值．第三军医大学学报, 2008, 30(14): 1367-1370.
[29]
张体江，龚启勇．磁化传递成像及其在精神疾病中的研究现状．磁共振成像, 2010, 1(6): 468-472.
[30]
Vavasour IM, Laule C, Li DK, et al. Is the magnetization transfer ratio a marker for myelin in multiple sclerosis? J Magn Reson Imaging, 2011, 33(3): 713-718.
[31]
Ikonomidou VN, Richert ND, Vortmeyer A, et al. Evolution of tumefactive lesions in multiple sclerosis: a 12-year study with serial imaging in a single patient. Mult Scler, 2013, 19(11): 1539-1543.

PREV Research progress of diffusion tensor imaging in gliomas invasion
NEXT Application of SPIO and 19F probes in magnetic resonance imaging to track in vivo immune cells
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn